Femasys Revenue and Competitors
Estimated Revenue & Valuation
- Femasys's estimated annual revenue is currently $10M per year.
- Femasys received $4.0M in venture funding in January 2017.
- Femasys's estimated revenue per employee is $200,800
- Femasys's total funding is $69M.
Employee Data
- Femasys has 50 Employees.
- Femasys grew their employee count by 4% last year.
Femasys's People
Name | Title | Email/Phone |
---|---|---|
1 | SVP, Regulatory & Clinical Affairs | Reveal Email/Phone |
Femasys Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $7.3M | 29 | N/A | N/A | N/A |
#2 | $104.7M | 417 | 3% | N/A | N/A |
#3 | $6M | 24 | -23% | N/A | N/A |
#4 | $5M | 40 | 0% | $16M | N/A |
#5 | $6M | 24 | -23% | N/A | N/A |
#6 | $10.8M | 43 | 5% | N/A | N/A |
#7 | $3M | 24 | 0% | $50M | N/A |
#8 | $10M | 40 | -13% | N/A | N/A |
#9 | $5M | 20 | 11% | N/A | N/A |
#10 | $17.6M | 70 | 3% | N/A | N/A |
What Is Femasys?
Our experienced management team has over 200 years of collective industry experience with extensive focus in medical devices. The pioneering and collaborative efforts of the management team have created an organization that strives for integrity in all actions, innovation in development activities, excellence in operations, and the highest quality products. The team is complemented by world-class medical advisors. Our products have been organically conceived, researched and developed by the Company and all manufacturing activities are conducted to ensure compliance with the U.S. Food and Drug Administration (FDA) per the requirements of 21 CFR 820, as well as ISO 13485. Femasys has achieved significant milestones to date, including numerous issued patents and filings, recruitment of a team of experts, clearance of multiple regulatory filings by the U.S. Food and Drug Administration (FDA), European Union, Canada, and Japan with other select countries in process. Making a difference in the lives of women one product at a time is a great privilege and serves to drive the Company's mission.
keywords:Biotechnology,Finance,Healthcare,Medical Devices,Medical Diagnostics,Pharmaceuticals$69M
Total Funding
50
Number of Employees
$10M
Revenue (est)
4%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Femasys News
Hedge funds have recently added to or reduced their stakes in the business. Millennium Management LLC bought a new stake in shares of Femasys in...
Femasys Inc. is a biomedical company aiming to meet women's needs worldwide by developing a suite of product candidates that include minimally...
Femasys Inc. is a biomedical company aiming to meet women's needs worldwide by developing a suite of product candidates that include minimally...
NEW YORK, June 21, 2021 /PRNewswire/ -- Chardan, a global investment bank, today announced that it acted as lead left bookrunner in the successful closing of the $34.45 million IPO of Femasys, Inc. (NASDAQ: FEMY) a biomedical company focused on transforming women's healthcare by developing novel ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $8.1M | 50 | 6% | $222.7M |
#2 | $13M | 50 | 0% | N/A |
#3 | $6.5M | 50 | -7% | $8.4M |
#4 | $6M | 50 | -12% | N/A |
#5 | $4.8M | 50 | 0% | N/A |
Femasys Funding
Date | Amount | Round | Lead Investors | Reference |
---|---|---|---|---|
2015-04-30 | $10.2M | B | Legacy Capital Partners | Article |
2016-08-16 | $3.3M | Undisclosed | Article | |
2016-12-16 | $40.0M | C | Salem Partners | Article |
2017-01-19 | $4.0M | Undisclosed | Salem Partners | Article |